The India-US trade deal has significantly improved India’s investment climate and export competitiveness, shifting the outlook for Indian equities to a decisive risk-on stance. With benchmark valuations below long-term averages, this reset creates headroom for multiple expansion alongside improving earnings visibility, particularly benefiting sectors like pharmaceuticals and gems.